Novartis sues to stop generic version of blockbuster MS drug
Clayton Utz 2021-03-15 11:06 am By Cat Fredenburgh | Melbourne
Please login to bookmark Close

Swiss drug giant Novartis has sued generic drug maker Pharmacor to halt its launch of a generic version of the company’s top-selling MS drug Gilenya.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au